FTC would review a new Merck/Sanofi-Aventis JV
Monday, 8 February 2010 by Ron Knox
Drug makers Sanofi-Aventis and Merck are expected to reignite their animal-health joint venture in the coming weeks, exposing the companies to a fresh round of antitrust scrutiny by the US Federal Trade Commission.
Subscription required to view this article
This content can only be accessed by GCR subscribers.
A subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current print and online content.
Please note: If you would like online access to all archived content, you will need a Premium subscription.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top